Results 241 to 250 of about 1,264,680 (377)

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Doses and Dose Titration of Bexicaserin in Healthy Participants in a Randomized, Double‐Blind, Placebo‐Controlled Study

open access: yesClinical Pharmacology in Drug Development, EarlyView.
Abstract Bexicaserin (LP352) is a selective superagonist of the 5‐hydroxytryptamine 2C (5‐HT2C) receptor currently in development for the treatment of seizures that arise from developmental and epileptic encephalopathies. This phase 1, double‐blind, placebo‐controlled multiple ascending dose (MAD) study assessed the safety, tolerability, and ...
Jonathan Williams   +7 more
wiley   +1 more source

Visual field progression patterns in the ocular hypertension treatment study correspond to vulnerability regions of the disc

open access: green
Ari Leshno   +6 more
openalex   +2 more sources

Rapid Identification of New Psychoactive Substances in Letters by LA‐APCI‐MS

open access: yesDrug Testing and Analysis, EarlyView.
Laser ablation coupled to molecular mass spectrometry utilizing a modified atmospheric pressure chemical ionization source was used for the detection of synthetic cannabinoid receptor agonists in infused prison mail samples. ABSTRACT New psychoactive substances (NPS), especially synthetic cannabinoid receptor agonists (SCRA), are increasingly smuggled ...
Mark Wesner   +4 more
wiley   +1 more source

Gene therapy for ocular hypertension using hfCas13d-mediated mRNA targeting. [PDF]

open access: yesPNAS Nexus
Chen S   +8 more
europepmc   +1 more source

Oxytocin Effects on Food Stimulus Processing and Food Intake in Females With or Without Binge Eating Disorder

open access: yesInternational Journal of Eating Disorders, EarlyView.
ABSTRACT Objective Binge eating disorder (BED) is maintained by increased food‐related incentive salience, which is reflected by an attentional bias for food. Oxytocin acutely attenuates this bias in patients with anorexia nervosa and reduces food intake in males with normal or increased body weight.
Julia Nannt   +6 more
wiley   +1 more source

TRPV4 activation by TGFβ2 enhances cellular contractility and drives ocular hypertension. [PDF]

open access: yesElife
Rudzitis CN   +9 more
europepmc   +1 more source

Rho Kinase Inhibitors as a Novel Treatment for Glaucoma and Ocular Hypertension.

open access: yesOphthalmology (Rochester, Minn.), 2018
A. Tanna, Mark Johnson
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy